Stocks of AN2 Therapeutics Inc (NASDAQ:ANTX) traded higher last session on Wall Street, down -5.38% to $1.23.
ANTX stock price is now 15.27% away from the 50-day moving average and -45.15% away from the 200-day moving average. The market capitalization of the company currently stands at $36.75M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target reduced from $5 to $1, Leerink Partners Downgraded its rating from Outperform to Market Perform for AN2 Therapeutics Inc (NASDAQ: ANTX). , while ‘Leerink Partners’ rates the stock as ‘Outperform’
In other news, Readnour Robin Shane, Director bought 150,000 shares of the company’s stock on Nov 19 ’24. The stock was bought for $155,258 at an average price of $1.04. Upon completion of the transaction, the Director now directly owns 560,073 shares in the company, valued at $0.69 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 20 ’24, Director Readnour Robin Shane bought 50,000 shares of the business’s stock. A total of $57,870 was incurred on buying the stock at an average price of $1.16. This leaves the insider owning 585,073 shares of the company worth $0.72 million. A total of 28.25% of the company’s stock is owned by insiders.
During the past 12 months, AN2 Therapeutics Inc has had a low of $0.87 and a high of $22.22. As of last week, the company has a debt-to-equity ratio of 0.00, a current ratio of 9.75, and a quick ratio of 9.75. The fifty day moving average price for ANTX is $1.0633 and a two-hundred day moving average price translates $2.3364 for the stock.
The latest earnings results from AN2 Therapeutics Inc (NASDAQ: ANTX) was released for 2024-06-30.
